FDA Import Refusal 286-7012499-0/12/4 — Amphastar Nanjing Pharmaceuticals Inc
The FDA refused shipment 286-7012499-0/12/4 from Amphastar Nanjing Pharmaceuticals Inc (China) on August 18, 2025. The refused product falls under Drugs and Biologics — HEPARIN SODIUM (ANTI-COAGULANT). Cited charge: 115 This firm has 1 other import refusal on record.
Refusal Details
- Date
- August 18, 2025
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 61LCS08 HEPARIN SODIUM (ANTI-COAGULANT)
- Charges
- 115